BNY Mellon Real Return remains a sound choice for investors seeking a competitive and risk-conscious dynamic allocation strategy. Portfolio complexity has gradually increased, though, and the process leaves significant room for execution. These concerns, coupled with the continued struggles to deliver alpha on a consistent basis relative to the Morningstar Category benchmark, lead to a lower Process Pillar rating.
BNY Mellon Global Real Return - A DRRAX Fund Analysis
Morningstar’s Analysis DRRAX
Will DRRAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar